| Scientific Name |
Canakinumab
|
|---|---|
| Brand Name |
Ilaris
|
| Risk |
Safety information about risks of Opportunistic infections, infections, Neutropenia, Immunogencity/Allergenicity, Malignancy, Immunogencity/Allergenicity, Malignancy, Disorders of lipoprotein metabolism, Macrophage activation syndrome, Interactions with Vaccines, Pregnancy and lactation.
|
| Educational Materials for Healthcare Professionals |
|
| Educational Materials for Patients |
|